首页> 外文期刊>BioTechnology: An Indian Journal >Serum CEA, SOX2 and CA50 RIA detection of lung cancer patients
【24h】

Serum CEA, SOX2 and CA50 RIA detection of lung cancer patients

机译:肺癌患者的血清CEA,SOX2和CA50 RIA检测

获取原文
           

摘要

Through the serum carcinoembryonic antigen (CEA), stem cell markers (SOX2), carbohydrate antigen 50 (CA50) and other tumor markers (TM) joint inspection methods, explore the correlation between TM and lung cancer, seeking to improve the diagnosis of lung cancer positive rate and the best means of prognosis. Methods: serum collected from 85 cases of lung cancer patients before treatment, after treatment, 6 weeks, 6 months, CEA, SOX2, CA50 was examined by ELISA assays, 25 patients diagnosed with non-lung cancer as control group. Results: CEA, SOX2, CA50 were significantly higher in experimental group than control group, the difference was significant (P <0 01.); Postoperative residual and metastatic tendency TM content does not fall significantly; serum CEA + SOX2 + CA50 joint testing positive rates of up to 91.2%, significantly higher than the single seizure (P <0. 01). Conclusion: combined serum CEA + SOX2 + CA50 can increase the positive rate of diagnosis of lung cancer; early diagnosis of lung cancer has an important role, especially with a specific value to evaluate the efficacy and postoperative metastasis.
机译:通过血清癌胚抗原(CEA),干细胞标志物(SOX2),糖类抗原50(CA50)和其他肿瘤标志物(TM)的联合检查方法,探讨TM与肺癌的相关性,以寻求改善肺癌的诊断阳性率和最好的预后手段。方法:采用ELISA法检测85例肺癌患者治疗前,治疗后6周,6个月的血清CEA,SOX2,CA50,以25例确诊为非肺癌的患者为对照组。结果:实验组CEA,SOX2,CA50明显高于对照组,差异有统计学意义(P <0。01)。术后残余和转移趋势TM含量没有明显下降;血清CEA + SOX2 + CA50联合检测阳性率高达91.2%,明显高于单次发作(P <0。01)。结论:血清CEA + SOX2 + CA50联合检测可提高肺癌的阳性诊断率。肺癌的早期诊断具有重要作用,尤其是对评估疗效和术后转移具有特定价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号